SUD in Anesthesia — Zero Stigma, Real Information

The data, without sugarcoating

Lifetime SUD prevalence in anesthesia is estimated at 10–20%, among the highest of any medical specialty. Fentanyl, propofol, volatile agents, and ketamine are the most commonly diverted substances. Relapse after a first SUD episode in an anesthesia provider carries elevated mortality because the first relapse is often fatal when it happens in isolation with access to high-potency agents.

The clinical implication: early intervention saves lives, and the recovery pathway for anesthesia providers differs from the general SUD population because of occupational access. This is why dedicated peer-assistance programs exist.

Risk factors specific to anesthesia

• Access. Controlled substances are the work product.
• Chronicity. Long hours, call, and circadian disruption.
• Secondary exposure. Trace aerosolized fentanyl and propofol exposure have been implicated in sensitization.
• Personality profile. High-achieving, self-reliant, uncomfortable asking for help.
• Family history. A strong personal/family addiction history warrants awareness, not exclusion.

Warning signs in a colleague

• Volunteering for cases with the highest opioid use; refusing breaks.
• Patients who seem inadequately medicated despite large charted doses.
• Unexplained presence in the OR suite on off-days.
• Frequent bathroom trips during cases, long sleeves in summer, weight loss.
• Mood lability, withdrawal from colleagues, missed commitments.
• Discrepancies in the controlled-substance record — wasting alone, unusual waste patterns.

These are not diagnostic. They are triggers to ask, privately and without accusation.

If it's you

1. Stop practicing today if you're using today. Call in sick. This is the highest-stakes hour of your career.
2. Call AANA Peer Assistance (1-800-654-5167). Confidential, not a report.
3. Talk to a healthcare attorney before talking to your employer if a complaint is already active. Hospital HR is not on your side in this scenario.
4. Accept the evaluation. Peer programs require independent assessment. Most providers start with 30–90 days of treatment followed by 3–5 years of monitoring.
5. Plan for the long game. Most anesthesia providers in monitoring do return to practice. The programs work when you work them.

If it's a colleague

Do not confront alone. Do not try to handle it off the record. The humane and protective path is:

1. Call AANA Peer Assistance for guidance before anything else.
2. Loop in a department leader you trust, privately.
3. Understand your state's reporting obligations — some states mandate reporting of impairment, others allow peer-program referral as a substitute.
4. Do not staff your colleague solo. Isolation is where fatal relapse happens.

Return to anesthesia practice

Return-to-practice is debated. Some programs support return to anesthesia with strict monitoring; others require specialty change. The evidence suggests return is feasible for providers in robust monitoring with naltrexone and a genuine recovery program, but relapse risk remains non-trivial. This is a decision to make with your program, your treatment team, and honest self-assessment.